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Thrombospondin-1 decreases NO-mediated vasodilation in coronary arterioles in 
advancing age 
 
Grant McKenzie, Christopher Nevitt, B.S., Amanda Jo LeBlanc, Ph.D., Cardiovascular 
Innovation Institute, University of Louisville, Louisville, KY 40202 
 
Matricellular protein thrombospondin-1 (Thbs-1), after binding to cellular receptor CD47, has 
previously been linked to decreased nitric oxide (NO)-mediated vasodilation in large arterial 
vessels through production of ROS, especially in a diseased state. Thbs-1 has been shown to be 
upregulated with advancing age. We wanted to assess Thbs-1-induced alterations on 
vasoreactivity in smaller vessels like the coronary arterioles to determine whether there are age-
related detriments of Thbs-1 signaling on vasoreactivity, as well as quantitatively assess the 
amount of oxygen radical production by vessels in an aging model.  
 
Coronary arterioles from young (4 mos) or old (24 mos) rats were isolated, cannulated, and 
pressurized for evaluation of smooth muscle cell (SMC) responsiveness to an exogenous NO 
donor with and without the presence of Thbs-1 (2.2 nmol/L), superoxide dimutase mimetic 
TEMPOL (1x10-4 M) and enzymatic catalase (3x10-6 M). Another set of arterioles were used to 
detect basal levels of ROS in the presence of O2!  specific fluorescent dye DHE (2x10-4 M). 
Images were obtained during baseline and after a 20-minute incubation with Thbs-1, or after a 
20-minute incubation with Thbs-1, TEMPOL, and catalase. Western immunoblots and RT-PCR 
analysis were used to probe for Thbs-1 and Thbs-1 mRNA, respectively, within both young and 
old microvessel samples. 
 
In the presence of Thbs-1, NO-mediated vasodilation is significantly decreased in vessels from 
aged rat populations (58±6%, n=5) as compared to young (73±2%, n=8). After incubation with 
ROS scavenger TEMPOL and enzymatic catalase, maximum relaxation to NO was restored in 
old vessels (75±3%, n=5) to levels comparable to that of old control groups (85±2%, n=8). O2! 
production is also increased in the presence of Thbs-1 in old (22±4 AU, n=4) rat populations as 
compared to young (12±2 AU, n=6).  
 
These findings suggest that targeting of the Thbs-1/CD47 axis is a promising therapeutic option 
for treating microvascular dysfunction in aged models. Our findings provide evidence that 
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Introduction 
Coronary heart disease (CHD), also known as coronary artery disease, is the most 
common cause of death for both men and women in the United States (National Heart, Lung, and 
Blood Institute, 2014). Furthermore, CHD risk and diagnosis increases with advancing age in 
human populations (Centers for Disease Control and Prevention, 2011).  Recent literature 
provides evidence that impairments in the coronary microcirculation can also cause or contribute 
to CHD (Lanza & Crea, 2010). Even with modern medicine, over 380,000 people died as a result 
of CHD in the United States in 2010 alone (Murphy, Xu, and Kochanek, 2013). Current 
therapeutic approaches to treating CHD consist of pharmacologic therapies to treat hypertension 
and high cholesterol, as well as surgical interventions, including coronary artery by-pass surgery 
and implantation of endovascular stents (National Institutes of Health, 2012). Currently, 
therapeutic treatment options of microvascular dysfunction in the heart are limited. Due to small 
size and inaccessibility within the heart, surgical by-pass and implantation of endovascular stents 
within coronary microvessels are not feasible treatment options. Pharmacologic therapies include 
regimens of anticoagulants, beta-blockers, and ACE inhibitors, but these drugs often have 
widespread undesirable physiological effects throughout the body and are often contraindicated 
in many patients (National Heart, Lung, and Blood Institute, 2014). Thus, a non-invasive, 
pharmacologic therapeutic treatment with high specificity for microvascular circulation would be 
the most desirable therapeutic approach to treating CHD. Unfortunately, current treatment 
options that fit such criterion are severely limited. 
Matricellular protein thrombospondin-1 (Thbs-1) has long been a widely studied protein 
in the field of cardiovascular research due to its anti-angiogenic properties, however, more 
recently Thbs-1 has been implicated in interrupting typical nitric oxide (NO)-mediated 
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vasodilation pathways. Recent literature now suggests that Thbs-1 is upregulated in aged models 
as compared to young. Our laboratory has shown that Thbs-1 is upregulated with advancing age 
in a regenerative cell population isolated from old rat donors as compared to cells isolated from 
young rat donors (Aird et al., 2015). Other reports have shown that Thbs-1 expression can be 
induced following ischemic injury to the heart (Frangogiannis et al., 2005), and has been linked 
to decreased NO-mediated vasodilation in large arterial vessels such as the aorta (Yao et al., 
2014). We wanted to assess the latter finding in smaller vessels, like the coronary arterioles, that 
are primarily responsible for distributing blood flow to the myocardium, to determine whether 
there are age-related alterations of Thbs-1 signaling. In aged rats (Hachamovitch, Wicker, 
Capasso, and Anversa, 1989) and humans (Egashira et al., 1993), coronary blood flow reserve 
and NO-dependent vasodilation are significantly decreased and may contribute to the increased 
risk for CHD as people age. The potential and likely relationship between advancing age, 
microvascular reactivity, and Thbs-1-induced vascular dysfunction has not yet been established. 
Endogenous NO Signaling Disruption by the Thbs-1/CD47 Axis 
The loss of NO signaling is a significant factor in cardiovascular disease (Chirkov & 
Horowitz, 2007). Thbs-1, after binding to its high affinity cell receptor CD47, is influential in 
governing cardiovascular cellular responses by interruption of typical NO-dependent pathways 
(Roberts, Miller, Rogers, Yao, and Isenberg, 2012). NO produced by endothelial nitric oxide 
synthase (eNOS) from the conversion of L-arginine to L-citrulline (Moncada et al., 1991), 
interacts with soluble guanylyl cyclase (sGC), which ultimately leads to vasodilation in vessels 
from the increased production of cyclic guanosine monophosphate (cGMP) (Ignarro, Buga, 
Wood, Byrns, and Chaudhuri, 1987). Thbs-1 is known to increase the amount of reactive oxygen 
species (ROS) superoxide radical (O2!) production in rodent aortas through NADH oxidase 
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activation (Csányi et al., 2012). This suggests a role of Thbs-1 in decreasing the functionality of 
the NO signaling pathway because NO is readily scavenged by ROS (Wink et al., 1995), which 
can have deleterious biological effects. A diagram of this physiological pathway is illustrated in 
Figure 1. In summation, ROS effectively acts as an NO scavenger, decreasing the amount of NO 
available for cellular signaling and subsequent vasodilation in the vasculature. Currently, there is 
very limited literature on the effect of Thbs-1 and ROS production in microvascular cells. 
 
Figure 1. The endothelial nitric oxide signaling pathway. Thbs-1 activates cell receptor CD-47, which in turn 
activates NADH oxidase thus increasing ROS production. The ROS can then react with NO to produce 
peroxynitrite, which affects the NO signaling pathway. 
 
Further Interactions of Thbs-1 
Thbs-1 has also been shown to bind to cell receptor CD36, and both CD47 and CD36 are 
associated with inhibition of NO-mediated production of sGC and thus cGMP (Isenberg et al., 
2006). However, the Thbs-1 inhibition of the NO-mediated sGC and cGMP vasodilatory 
pathway is still present in CD36-null animals, but not in CD47-null animals, suggesting that the 
CD47-mediated inhibitory pathway is independent from CD36 (Isenberg et al., 2006), and 
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supports the finding that Thbs-1/CD47 axis is more influential in NO signaling pathway 
interruptions. There are also multiple members of the Thrombospondin family of proteins that 
bind to CD47, however, the Thbs-1/CD47 protein complex has a substantially stronger binding 
affinity as compared to interactions of the other members of the Thrombspondin family with 
CD47, once again further suggesting the Thbs-1/CD47 signaling axis is the most influential and 
potent with regards to NO signaling pathway interruptions (Isenberg et al., 2009). 
Thbs-1 is found in healthy adult plasma at physiological levels around 20 µg/L (Bergseth, 
Lappegård, Videm, and Mollnes, 2000), however, Thbs-1 levels are shown to be upregulated in 
several types of cardiovascular disease, such as in diabetic rat models (Stenina et al., 2003) and 
following ischemic injury to the heart (Frangogiannis et al., 2005). Furthermore, Thbs-1 
detrimentally regulates angiogenesis by sequestering vascular endothelial growth factor (VEGF), 
a signaling protein known for stimulating vasculogenesis and angiogenesis (Laklai et al, 2009). 
Thbs-1 has also been shown to increase systemic blood pressure and decrease arterial flow in the 
peripheral vasculature (Csányi et al., 2012). Thus, by Thbs-1 being an inhibitor of the NO 
signaling pathway, but potentially being increasingly expressed with age and after ischemic 
injury, Thbs-1 expression may play a significant role in cardiovascular disease, particularly in 
aged models, and potentially be a future target for cardiovascular therapeutics related to ischemia 
and microvascular dysfunction.  
Through hypothesis driven investigation, we wanted to evaluate the mechanistic detail of 
how the Thbs-1/CD47 signaling axis contributes to microvascular dysfunction with regards to 
aging. In our overall hypothesis, we expect that Thbs-1, through production of ROS, will 
significantly decrease NO-mediated vasodilation in coronary arterioles in aged rat populations. 
We also expect in the presence of Thbs-1, ROS production will be increased in aged rat coronary 
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arterioles, and that the negative effects of ROS on the NO signaling pathway can be recovered by 
use of a ROS scavenger. 
Methods 
Animals 
Young (4 mos) and Old (24 mos) Fischer-344 female rat hearts were explanted for 
microvessel harvesting. All animal procedures were approved by the Institutional Animal Care 
and Use Committee at the University of Louisville. The protocol was compliant with the Guide 
for the Care and Use of Laboratory Animals (National Institutes of Health, revised 2011). 
Microvessel Preparation  
A resistance vessel (<150 µm) branching from the left anterior descending artery was 
dissected and cannulated with resistance-matched micropipettes (Living Systems 
Instrumentation). Vessels that did not present leaks were then pressurized at 45 mmHg and 
warmed to 37°C for ~30 minutes until spontaneous tone developed. Only vessels that developed 
spontaneous tone (>20%) were used to assess vessel reactivity. Spontaneous tone was calculated 
as the percent constriction relative to maximum luminal vessel diameter using the formula: 
Spontaneous tone (%) = (Dmax - Db) ⁄ Dmax X 100, where Dmax is the maximum luminal vessel 
diameter recorded at a pressure of 45 mmHg under Ca2+-free conditions and Db is the steady-
state baseline vessel diameter achieved after the vessel warmed to 37°C (LeBlanc et al., 2009). 
Vessel relaxation was calculated as a percent using the formula: Relaxation (%) = [(Ds  - Db) ⁄ 
Dmax - Db)] X 100, where Ds is the measured arteriole diameter at each respective stage, Db is the 
diameter recorded immediately before initiation of the concentration response, and Dmax is the 
maximum luminal vessel diameter at a pressure of 45 mmHg under Ca2+-free conditions 
(LeBlanc et al., 2009). 
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Evaluation of vasodilator responses to NO 
Spontaneous NO donor Dea-NONO-ate was used to assess smooth muscle cell 
responsiveness to NO. As a control, vessel responsiveness was measured using only Dea-
NONO-ate in the absence of Thbs-1. Subsequently, vessel responsiveness to NO was measured 
in response to 60-minute incubations with Thbs-1 (2.2 nmol/L) (Yao et al., 2014), or a 60-minute 
incubation with Thbs-1 (2.2 nmol/L), superoxide dismutase mimetic TEMPOL (1x10-4 M) 
(Nurkiewicz & Boegehold, 2007), and H2O2 scavenger enzymatic catalase (3x10-6 M) (Emsley et 
al., 1999) in both young and old groups. Logarithmic concentration response curves were 
generated as increasing cumulative amounts of NO are added in the presence of the vessel  
(1x10-9 M-1x10-4 M, 2-minute stages). Changes in vessel luminal diameter were measured using 
a video caliper (Colorado Video). 
Reactive Oxygen Species Production 
Fluorescent dye dihydroethidium (DHE) was used to evaluate intravascular ROS levels at 
baseline and in the presence of Thbs-1 as described previously (LeBlanc et al., 2010). In the 
presence of O2!, DHE is converted to ethidium bromide, which intercalates into cellular DNA. 
To evaluate intravascular ROS, a subsection of coronary arterioles were cannulated as described 
above and DHE (2x10-4 M) was infused intraluminally and incubated for 10-minutes, then 
flushed out with 1 mL PSS and the vessel was warmed to 37°C. Images were obtained at 
baseline and after a 20-minute incubation with Thbs-1 (2.2 nmol/L), or after a 20-minute 
incubation with Thbs-1, TEMPOL, and catalase. A mercury lamp was used for fluorescent 
excitation. Images were then analyzed using NIS-Elements imaging software to measure changes 
in mean fluorescent intensity, calculated as average fluorescence intensity per pixel by surface 
area. Fluorescent values from the 20-minute incubation were then subtracted from the baseline 
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image to measure changes in mean fluorescent intensity across treatments. 
Immunoblot analysis 
Microvessels (5-6, pooled) and a positive control spleen were homogenized in ice-cold 
lysis buffer and protein subsequently quantified with a Bradford assay (Bio-Rad, Hercules, CA). 
A protein amount of 9 µg for microvessel samples and 5 µg for positive control mouse spleen 
was resolved by SDS-PAGE (4-20%, Bio-Rad) and transferred onto nitrocellulose membrane 
(Bio-Rad). Blots were probed with primary antibodies for Thbs-1 (1:500; Thermo Scientific) or 
β-actin (1:1,000; Santa Cruz) and a secondary antibody (1:2,000; Thermo Scientific), and 
visualized on an Amersham Typhoon 9400 Imager (GE Lifesciences). Thbs-1 and loading 
control β-actin presence were assessed in the young and old groups.  
Reverse transcription PCR analysis 
Reverse transcription polymerase chain reaction (RT-PCR) analysis protocol was 
previously adapted from Nunes, Rekapally, Chang, and Hoying (2011). A Sybr-green-based, RT-
PCR was performed to determine the relative expression of Thbs-1. Microvessel tissues for RNA 
isolation were homogenized in RNA-Bee (Tel-test Inc.). After homogenization, samples were 
incubated at ambient temperature for 10 min and centrifuged with the addition of chloroform 
over a phase-lock gel (5Prime, Inc. Gaithersburg, MD). Total RNA was isopropanol precipitated 
in the presence of 1 ml/ml of GlycoBlue (Ambion). 1 µg of total RNA was used to generate 
cDNA by reverse transcription using the AffinityScrip QPCR cDNA Synthesis Kit (Agilent 
Technologies). Primers were designed using the Primer 3 web program. For each sample, 
average threshold values of triplicate runs for each gene per sample were normalized to 
Dynactin1 values (ΔCt) to account for template loading. ΔΔCt values, the difference in 
threshold cycles for samples of interest and control samples, were calculated as: control sample 
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ΔCt – sample of interest ΔCt. Expression values were reported as: normalized target gene 
expression levels = 2ΔΔCt. Primer sequences for PCR can be found in Table 1. 
 
Gene Forward Primer Reverse Primer 
Thbs-1 CGG TTT GAT CAG AGT GGT GA CGG CAC TCG TAT TTC ATG TC 





Animal and Vessel Characteristics 
 A summary of animal and vessel characteristics is listed below in Table 2. Body weight 
and heart weight increased with age between the young and old female rat groups. Advancing 
age did not significantly affect spontaneous tone percentage nor did it affect initial steady-state 
vessel diameter of the coronary arterioles from rats. These values are congruent with data 
previously reported by LeBlanc et al. (2009). Significant decreases of spontaneous tone occurred 
following Thbs-1 and Thbs-1 + TEMPOL groups as compared to baseline spontaneous tone in 
young female rats. 
Table 1. Primer sequences for RT-PCR. 




Vasodilator Responses to NO 
There were no differences in overall concentration-response curves between young and 
old isolated coronary arterioles from young and old female rats with exogenous NO donor Dea-
NoNo-ate (P < 0.05; Fig. 2). These results align with values reported by LeBlanc et al. (2009). In 
the presence of a physiological concentration of Thbs-1, NO-mediated vasodilation was 
decreased in coronary arterioles from old rats (P < 0.05; Fig 3.). However, in the presence of 
TEMPOL, or in the presence of TEMPOL and enzymatic catalase, age-related differences in 
Thbs-1-induced decreases of NO-mediated vasodilation in isolated arterioles from young and old 
female rats were abolished (Fig 4. & Fig 5.). For young females, in the presence of Thbs-1, NO-
mediated vasodilation was not significantly altered (Fig 6.). In old females, however, in the 
Table 2. Animal and vessel characteristics for isolated vessel reactivity experiments. ^ indicates 
significant difference from young, P≤0.05. * Indicates significant within-groups difference from 
baseline spontaneous tone 
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presence of TEMPOL and catalase, coronary vessels from old rats were able to recover from 
Thbs-1 induced decreases in NO-mediated vasodilation. (P < 0.05; Fig 7.). 
Maximum vessel relaxation in both young and old females was also inhibited by the 
presence of Thbs-1 compared to DEA alone. In the presence of Thbs-1, young rat arterioles 
exhibited a decreased ability to vasodilate in the presence of NO donor Dea-NoNo-ate (P < 0.05; 
Fig. 8.) as compared to the DEA control groups. Maximum vessel relaxation in old rats exhibited 
the same trend as the young rats, as the Thbs-1 group displayed an attenuated response to Dea-
NoNo-ate, however, maximum vessel relaxation in the presence of Thbs-1was partially restored 
in old rats when pretreated with TEMPOL + Catalase (P < 0.05; Fig 9.). This finding was not 
observed in the young rat group, indicating another age-related difference between groups. 
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Reactive Oxygen Species Production 
 In the presence of Thbs-1, mean endothelial O2! production was increased significantly 
in both young and old rat groups as compared to a 20-minute control baseline fluorescence (P < 
0.05; Fig 10c.). To standardize against differences in starting baseline fluorescence of vessels, 
the 20-minute Thbs-1 incubation fluorescent images were subtracted from the 0-minute baseline 
images. Age related differences were observed in vessel O2! production in the presence of Thbs-
1, as old vessels had significantly greater increases in O2! production after 20-minute 
incubations with Thbs-1 as compared to young vessels (P < 0.05; Fig 10c.). Vessel treatment 
with Thbs-1, TEMPOL, and catalase significantly lowered endothelial fluorescence to levels 
comparable to that of both young and old control vessel groups (P < 0.05; Fig 10c). This 
suggests that there is less Thbs-1 induced O2! production in the presence of both TEMPOL and 
catalase.  
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Immunoblot analysis 
 An image of a sample blot probing for Thbs-1 and loading control β-actin can be seen in 
Figure 11. After multiple attempts, Thbs-1 remained undetected in microvessel samples while 
consistently appearing in spleen samples. These data suggests that Thbs-1 is not detectable in 
microvessel samples by Western immunoblots under normal physiological conditions.  





Reverse transcription PCR analysis 
 Relative expression of Thbs-1 mRNA in both young and old microvessel samples 
obtained through qRT-PCR can be seen in Figure 12. Thbs-1 signals were normalized to 
Dynactin1 values (ΔCt) of each sample to account for cDNA template loading. ΔCt values 
were then again normalized to Thbs-1 signals of young animals (ΔΔCt). There were no 
significant differences detected between normalized target gene expression levels for Thbs-1 





Figure 11. A representative immunoblot from microvessel samples of Thbs-1 and loading 
control β-actin. Samples were comprised of old female rat arterioles treated with young female 
rat regenerative cells (OF+ySVF), old female rat arterioles treated with old female rat 
regenerative cells (OF+oSVF), young female control microvessels (YC), and old control female 
microvessels (OC). Thbs-1 was undetected in microvessel tissues, but appeared in positive 
control mouse spleen samples. 















We found that in the presence of physiological levels of Thbs-1 (Yao et al., 2014), NO-
mediated vasodilation of isolated microvessels is negatively affected in aged populations as 
compared to young rats (Fig. 3), and this effect can be partially ameliorated by use of superoxide 
dismutase mimetic TEMPOL and enzymatic catalase (Fig. 7). These data aligns with the findings 
of Yao et al. (2014) that Thbs-1 decreases NO-mediated vasodilation in large arterial vessels. We 
now extend this finding to smaller vessels such as the coronary arterioles. Without catalase 
added in conjunction with TEMPOL, no vessel relaxation recovery was observed in 
concentration response curves in Thbs-1 treated arterioles for either young or old groups, 
suggesting that the additional peroxide byproduct of the radical oxygen scavenging pathway 
Figure 12. RT-PCR measurement of mRNA expression of Thbs-1 in young and old coronary 
arteriole samples. RNA expression is presented as ΔΔCt values that are first normalized to 
sample Dyn1 values, then normalized to Thbs-1 expression in spleen samples. 
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prevents this mechanism and promotes vasoconstriction (Figs. 4 & 5). In both young and old rat 
groups, maximum vessel relaxation in the presence of Thbs-1 was significantly decreased as 
compared to baseline, providing further evidence of Thbs-1 attenuating vascular responses to 
NO-mediated dilatory pathways (Figs. 8 & 9). With treatment of Thbs-1, TEMPOL, and 
catalase, these significant decreases in maximum vessel relaxation as compared to baseline were 
no longer observed in both young and old rat groups.  
DHE fluorescent data is congruent with the reporting of Csányi et al. (2012) that Thbs-1 
increases superoxide radical (O2!) production in rodent aortas, likely through NADH oxidase 
activation. We now demonstrate this finding in arterial microvessels, and show that Thbs-1 
increased ROS production in both young and old coronary arterioles (Fig. 10c). When subtracted 
from baseline fluorescence, old coronary arterioles produced significantly more ROS as 
compared to young coronary arterioles, indicating that old coronary arterioles are more sensitive 
to Thbs-1 as compared to young coronary arterioles following incubation with Thbs-1. This age 
related difference might provide possible explanation as to why NO-mediated vasodilation was 
attenuated in old rats in the presence of Thbs-1 as compared to young rats (Fig. 3) due to the 
increased production of ROS.  
Although Thbs-1 was not detectable via Western immunoblot analysis in microvessel 
samples, qRT-PCR data gives some evidence that Thbs-1 mRNA expression may possibly be 
elevated in old rat microvessels as compared to young rat microvessels, but more experimental 
samples will needed to establish possible statistical significance. It is important to note that Aird 
et al. (2015) reported that Thbs-1 is detectable in greater amounts in old regenerative cell 
samples isolated from rats as compared to young cell samples, which gives evidence that Thbs-1 
may be expressed more in aged models as compared to young. The aforementioned data for both 
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NO-concentration response curves and DHE fluorescence provides evidence of coronary 
microvascular sensitivity to Thbs-1, especially in aged models. With a potentially increased 
expression and sensitivity of Thbs-1 in old rat coronary arterioles and a decreased responsiveness 
to NO-mediated vasodilation, our findings suggest Thbs-1 is potentially detrimental to the aging 
vasculature.   
 These findings suggest that targeting of the Thbs-1/CD47 axis is a promising therapeutic 
option for treating microvascular dysfunction in aged models. Where current surgical approaches 
and pharmacological therapies fail in providing treatment of diseased microvascular circulation, 
knockout of the Thbs-1/CD47 axis through antibody or morpholino oligomer-mediated 
treatments may provide a novel, noninvasive, and highly specific approach to treatment of 
microvascular dysfunction. The development of such a therapeutic treatment would have 
widespread benefits in combatting CHD, the most common cause of death for both men and 
women in the United States (National Heart, Lung, and Blood Institute, 2014).  
One limitation of this study is low numbers in several experimental sample groups. 
Although statistically significant, findings can be further validated by increasing experimental 
group sample size. Future studies will be aimed toward further exploration of the Thbs-1/CD47 
signaling pathway and investigating therapeutic treatment options involving Thbs-1 and CD47, 
specifically through development of a CD47-knockout line of rats and performing controlled 
testing of their vascular functionality. Furthermore, the interaction between Thbs-1 and CD36 
needs to be investigated to uncover the effects that CD36 might have on microvascular function. 
Our findings provide direction toward a future avenue of cardiovascular therapeutics designed to 
target the Thbs-1/CD47 axis, which may potentially alleviate symptoms of vascular senescence.  
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